Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FBWFU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,121
Award facts
- Contract value 100% obligated
- $14,120.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,120.82 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on June 18, 2025, with an ultimate completion date of June 20, 2025. This competitively awarded, firm fixed price contract involves no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication commonly used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and asthma, indicating this delivery order supports pharmaceutical needs within the federal healthcare supply chain.
This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for the Defense Health Agency and military healthcare systems, providing a comprehensive range of medications, vaccines, and medical supplies through competitively awarded contracts. The company's portfolio demonstrates extensive experience fulfilling federal medical procurement requirements across multiple therapeutic domains, supporting military personnel and veteran healthcare initiatives globally.
Quick answers
Who was awarded contract SPE2DB25FBWFU?
SPE2DB25FBWFU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FBWFU worth?
The government has obligated $14,121 on SPE2DB25FBWFU.
Is contract SPE2DB25FBWFU an order under another contract?
Yes. SPE2DB25FBWFU is a delivery order under SPE2DB24D2012, an indefinite delivery contract.
Was contract SPE2DB25FBWFU competed?
The extent of competition for SPE2DB25FBWFU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award